Open AccessAfter proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?
Author(s) -
Zaid Ahmad Wani,
Riyaz A Baht,
Ajeet Singh Bhadoria,
Rakhi Maiwall,
Yamin Majeed,
Afaq Ahmad Khan,
Showkat Ali Zargar,
Mohd A Shah,
Kaiser M Khan
Publication year - 2015
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.164207
Subject(s) - medicine , chronic liver disease , carvedilol , ascites , portal venous pressure , adverse effect , gastroenterology , liver disease , blood pressure , portal hypertension , cardiology , cirrhosis , heart failure
Literature regarding safe doses of carvedilol is limited, and safe doses across different Child classes of chronic liver disease are not clear.